March 16, 2020 - Following the development of new billing codes, CMS is now letting clinical laboratories know how much they will receive in Medicare reimbursement for testing patients for COVID-19.
CMS emailed providers last week with a pricing list for COVID-19 diagnostic tests. The list stated that laboratories testing patients for the novel coronavirus using the CDC’s test will receive about $36 in Medicare reimbursement, while those non-CDC test kits will receive about $51.
However, CMS pointed out in the email that “prices may vary slightly depending on the local Medicare Administrative Contractor (MAC).”
CMS emailed providers last week with a pricing list for COVID-19 diagnostic tests. The list stated that laboratories testing patients for the novel coronavirus using the CDC’s test will receive about $36 in Medicare reimbursement, while those non-CDC test kits will receive about $51.
However, CMS pointed out in the email that “prices may vary slightly depending on the local Medicare Administrative Contractor (MAC).”